Articles
The Aesthetic Tech Forum 2024 is underway (January 25th and 26th) and features a session titled “Revitalizing Radiance: Advances in Hair Restoration“. Panelists include: Wajdie Ahmad, Executive Chairman & COO of Amplifica Holdings Group, Inc.; Amplifica is a biopharmaceutical company with several treatments in the pipeline targeted towards androgenic alopecia (AMP-303, AMP-203, and AMP-601). Drew…
Read More
Positive news to start the new year with Hope Medicine’s HMI-115 Phase 1b results announced on January 14th, 2024. Successful Results for Male Participants Hope Medicine has released positive data from their Phase 1b trial conducted in Australia titled, “An Open-Label Study, to Evaluate Safety, Tolerability, and Efficacy in Male and Female with Androgenetic Alopecia…
Read More
Another Korean company has emerged with an exciting and potentially world-first approach to developing new hair loss therapies using hair follicle organoids. Kangstem Biotech Kangstem Biotech was established in 2010 and has several stem cell therapies in the pipeline for atopic dermatitis, rheumatoid arthritis, and osteoarthritis. Recently, Kangstem Biotech announced an expansion into hair loss…
Read More
Hair Cloning Research Expanding There has been no shortage of hair cloning news in the world of late, which is a good thing. In fact, three out of my four recent articles featured different hair cloning treatment modalities. This article will discuss more, and you can expect even more hair cloning news coming soon to…
Read More
Published on: Oct 7, 2020 at 20:04
Read More
The long awaited phase 2 trial of Hope Medicine’s HMI-115 in androgenetic alopecia has officially begun. HMI-115 Antibody Starts Phase 2 Trial It has almost been two full years since Hope Medicine issued an exciting press release which announced the company’s approval to conduct a phase 2 clinical trial with the US FDA. Since then,…
Read More
Follicle Thought is pleased to share an exclusive interview with the CEO of OrganTech as we draw closer to 2024. OrganTech Inc. Resurgence Prior to the year 2020, one researcher’s name was held synonymously with the topic of hair cloning by online hair-seeking communities – Dr. Takashi Tsuji, and most often, just “Tsuji.” The…
Read More
TrichoSeeds Co., a biotech founded by Junji Fukuda PhD, has announced a timeline for the start of its hair cloning clinical trial. Note, the snippet above taken from the ko-karie.com website has been edited since the publishing of this article. Luckily, we caught a screenshot of it before the change was made. The…
Read More
Epibiotech EPI-001 Approval by the Ministry of Food and Drug Safety Update (12/21/2023) As of December 21st, 2023, Epibiotech has been approved by the Ministry of Food and Drug Safety to start Phase 1/2a clinical trials for its EPI-001 autologous dermal papilla cell treatment to treat androgenetic alopecia. Safety will be measured in Phase 1…
Read More
China Trial Enrolls 180 Patients To Complete Enrollment: Update (8/22/23) On August 22, 2023, Kintor Pharmaceutical announced the completion of patient enrollment in a phase 2 trial in China for GT20029. This means all of the patients needed to complete the study have been enrolled, and will undergo their dosing schedule over the next 12…
Read More